Company dossiers
Company dossiers that connect clinical evidence, financial reality, and the next catalyst.
Checking session…
Private biotech intelligence
Read the science.
Find the edge.
The headline moves the stock.
The research builds the conviction.
Go inside the trials, the cash, and the catalysts. BioDosier connects the evidence to the investment thesis: where the opportunity lies, what could go wrong, and what changes the call.
Sign in with Google
Enter the research desk. Access for approved accounts.
Investment theses
Investment theses with the upside, the risks, and explicit entry and exit conditions.
A record you can learn from
Calls recorded. Outcomes tracked. A research process that can learn from both.
Today
The leads the desk wants a decision on today. Each one carries the machine's call, the thesis behind it, the entry and exit conditions, and the evidence. You decide whether to buy it, and you grade the machine's call. Both are kept under your name and scored at the thesis horizon.
Loading today's queue…
Loading this lead…
Dossier universe
Scannable index of research coverage. The machine fills this over time — coverage is the progress reading, not the row count alone.
Loading dossiers…
Loading dossier…
Portfolio & Alpha
Live management of approved Buys, thesis exit execution, multi-benchmark alpha (SPY, QQQ, XBI), and Book M algorithm performance.
Loading portfolio and books…
Preferences
Where leads and grading feedback go on Telegram, and who may grade. Admin-only: these are routing and access settings, not grading itself.
Loading preferences…
Sector research
Follow a source into the price tape, and keep the unexplained part visible.
Loading sourced research…